Found 27 Diabetes Mellitus, Type 1 trials
A listing of Diabetes Mellitus, Type 1 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
R
Rebecca Ellis
What is this study about?The purpose of this study is to explore how people's openness to social support influences their use of social support to improve how they take their prescribed medications to manage their diabetes.Who can take part?English-speaking adults ≥18 years old with a confirmed medical diagnosis of type …
This project will evaluate FoRKS (home delivered foods and kitchen skills intervention) versus enhanced usual care (EUC) for middle-aged safety-net primary care patients who screen positive for food insecurity and hypertension. This is a randomized clinical trial (RCT) testing the feasibility and initial efficacy of FoRKS to impact mean systolic …
M
Mary de Groot, PhD
What is the purpose of this study?This research is being done so that we can learn more about helping adults with type 2 diabetes who want to improve their diabetes self-management behaviors. Specifically, we are testing an online group treatment called Finding Your Balance with Diabetes.
M
Mary de Groot, PhD
Why is this study being done?This research is being done so that we can learn more about helping Black and African-American women who want to improve their diabetes self-care behaviors. Specifically, we are testing a treatment called Diabetes Tune-Up Group. You can choose to complete the treatment either online or …
C
Carmella Evans-Molina, MD
The purpose of this study is to identify biomarkers (small molecules in the blood) that can predict those people at risk of developing Type 1 diabetes.
L
Linda DiMeglio, MD
What is the purpose of this study?This study is the long-term extension of the PRV-031-001 (PROTECT) study. PROTECT is a Phase 3, randomized, double-blind, placebo-controlled, multinational, multi-center study to evaluate the efficacy and safety of teplizumab, a humanized, anti-CD3 monoclonal antibody, in children and adolescents ages 8 through 17 recently …
T
Tamara Hannon, MD
We propose a study that incorporates mind-body skills with diabetes education specifically designed for adolescents with T1D. To our knowledge, this is the first of such a study in adolescents with T1D.
T
Tamara Hannon, MD
To confirm superiority of oral semaglutide at the maximum tolerated dose (3 mg, 7 mg or 14 mg)versus placebo on glycaemic control in children and adolescents (age 10 to less than 18 years) with type 2 diabetes on a background treatment of metformin or basal insulin or both.
C
Carmella Evans-Molina, MD
RADIANT aims to discover and define rare and atypical forms of diabetes among individuals and families, by investigating and defining their molecular and metabolic bases, and developing processes as well as a database and biorepository to enhance further understanding of atypical diabetes by the broader research community. These refined …
E
Evan Fogel, MD
Researchers at Indiana University School of Medicine are conducting a study to find out how many people with acute pancreatitis develop diabetes. Diabetes is a known complication of acute pancreatitis. For some people, diabetes can last a few weeks after acute pancreatitis, but for others, it can appear a year or …
